Author:
Nauck Friedemann,Benze Gesine
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Arzneimittelkommission der Deutschen Ärzteschaft (2007) Empfehlung zur Therapie von Tumorschmerzen. Arzneiverordn Prax 34(Sonderheft 1)
2. AWMF (2020) https://www.awmf.org/fileadmin/user_upload/Leitlinien/145_Schmerzgesellschaft/145-003pw8_S3_LONTS_2020-04.pdf. Zugegriffen: 1. Aug. 2022
3. Bonica JJ, Wall PD, Melzack R (Hrsg) (1985) Textbook of pain. Livingstone, Edinburgh
4. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G, European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care (EAPC) (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58–e68
5. Diener KM (1996) Bisphosphonates for controlling pain from metastatic bone disease. Am J Health Syst Pharm 53:1917–1927